Last edition
News about "Gazyva (obinutuzumab)"
FDA Approves Genentech's Gazyva for Treatment of Lupus Nephritis
The US Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab), developed by Genentech, for the treatment of adults with lupus nephritis (LN), also known as lupus-related kidney disease.
Gazyva (obinutuzumab) | 21/10/2025 | By Dineshwori | 186
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members